{"id":4742,"date":"2015-03-04T17:23:03","date_gmt":"2015-03-04T15:23:03","guid":{"rendered":"http:\/\/www.ced.org.tr\/?p=4742"},"modified":"2015-03-04T17:23:03","modified_gmt":"2015-03-04T15:23:03","slug":"ms-ilaci-icin-sgk-onayi-bekleniyor","status":"publish","type":"post","link":"http:\/\/www.ced.org.tr\/?p=4742","title":{"rendered":"MS ilac\u0131 i\u00e7in SGK onay\u0131 bekleniyor"},"content":{"rendered":"<p><b>M\u0130LL\u0130YET, 3 Mart 2015<\/b><\/p>\n<p>T\u00fcrk Eczac\u0131lar\u0131 Birli\u011fi, MS hastalar\u0131n\u0131n kulland\u0131\u011f\u0131 ila\u00e7larda 4 ayd\u0131r s\u0131k\u0131nt\u0131 ya\u015fand\u0131\u011f\u0131 iddialar\u0131na yan\u0131t verdi. Genel Sekreter Harun K\u0131z\u0131lay, Gilenya ve Tecfidera&#8217;n\u0131n temini konusunda bir s\u0131k\u0131nt\u0131 olmad\u0131\u011f\u0131n\u0131 ancak Sosyal G\u00fcvenlik Kurumu&#8217;nun Tysabri isimli ilac\u0131n kullan\u0131m\u0131na dair de\u011fi\u015fiklik yapt\u0131\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131.<\/p>\n<p>K\u0131z\u0131lay, &#8220;Gilenya isimli ila\u00e7, piyasada 2 y\u0131ld\u0131r ruhsatl\u0131 ama geri \u00f6deme listesinde olmad\u0131\u011f\u0131 i\u00e7in temininde s\u0131k\u0131nt\u0131lar ya\u015fansa da biz TEB olarak yurtd\u0131\u015f\u0131ndan getiriyorduk. \u015eimdi SGK bu ilac\u0131 da geri \u00f6demeye ald\u0131. Ancak \u00fcretici firma T\u00fcrkiye genelinde t\u00fcm eczanelerde sat\u0131labilmesi i\u00e7in 3 ay s\u00fcre istemi\u015f. Bu 3 ayl\u0131k zaman diliminde biz TEB olarak ilac\u0131 yurtd\u0131\u015f\u0131ndan getirmeye devam edece\u011fiz. Tysabri adl\u0131 ilac\u0131n kullan\u0131m ko\u015fulu de\u011fi\u015fti. Hastan\u0131n bu ilac\u0131 alabilmesi i\u00e7in \u00f6nce Gilenya kullanmas\u0131 \u015fart\u0131 getirildi. Tedirginli\u011fimizi resmi bir yaz\u0131 ile SGK&#8217;ye bildirdik&#8221; dedi.<\/p>\n<p>T\u00fcrkiye&#8217;de 40 bin MS (Multipl Skleroz) hastas\u0131 bulunuyor. Uzmanlar MS&#8217;e kar\u015f\u0131 koruyucu tedavi konusunda son y\u0131llarda \u00f6nemli mesafeler al\u0131nd\u0131\u011f\u0131n\u0131, d\u00fczenli kullan\u0131lan ila\u00e7lar sayesinde ataklar\u0131n engellenebildi\u011fine dikkat \u00e7ekiyor. Hastalarda kal\u0131c\u0131 hasarlar olu\u015fmamas\u0131 i\u00e7in ila\u00e7lar\u0131n hayati \u00f6nemde.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>M\u0130LL\u0130YET, 3 Mart 2015 T\u00fcrk Eczac\u0131lar\u0131 Birli\u011fi, MS hastalar\u0131n\u0131n kulland\u0131\u011f\u0131 ila\u00e7larda 4 ayd\u0131r s\u0131k\u0131nt\u0131 ya\u015fand\u0131\u011f\u0131 iddialar\u0131na yan\u0131t verdi. Genel Sekreter&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_monsterinsights_skip_tracking":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[62],"tags":[],"class_list":["post-4742","post","type-post","status-publish","format-standard","hentry","category-sagliktan-haberler"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.3 - aioseo.com -->\n\t<meta name=\"description\" content=\"M\u0130LL\u0130YET, 3 Mart 2015 T\u00fcrk Eczac\u0131lar\u0131 Birli\u011fi, MS hastalar\u0131n\u0131n kulland\u0131\u011f\u0131 ila\u00e7larda 4 ayd\u0131r s\u0131k\u0131nt\u0131 ya\u015fand\u0131\u011f\u0131 iddialar\u0131na yan\u0131t verdi. Genel Sekreter Harun K\u0131z\u0131lay, Gilenya ve Tecfidera&#039;n\u0131n temini konusunda bir s\u0131k\u0131nt\u0131 olmad\u0131\u011f\u0131n\u0131 ancak Sosyal G\u00fcvenlik Kurumu&#039;nun Tysabri isimli ilac\u0131n kullan\u0131m\u0131na dair de\u011fi\u015fiklik yapt\u0131\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. K\u0131z\u0131lay, &quot;Gilenya isimli ila\u00e7, piyasada 2 y\u0131ld\u0131r ruhsatl\u0131 ama geri \u00f6deme listesinde olmad\u0131\u011f\u0131\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"CED \u0130STANBUL\"\/>\n\t<meta name=\"google-site-verification\" content=\"4\/PADeybIVXNi1FWDn2PVVeqiyUv8gGZqu7DNmOEZBNDKJiHEdIk47RKA\" \/>\n\t<meta name=\"msvalidate.01\" content=\"4\/PADeybIVXNi1FWDn2PVVeqiyUv8gGZqu7DNmOEZBNDKJiHEdIk47RKA\" \/>\n\t<meta name=\"p:domain_verify\" content=\"-01Tt29FgD8frNEEpRik8kzbF8-9TRCVGsm93a0wCBA\" \/>\n\t<meta name=\"keywords\" content=\"sa\u011fl\u0131ktan haberler\" \/>\n\t<link rel=\"canonical\" href=\"http:\/\/www.ced.org.tr\/?p=4742\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.3\" \/>\n\n\t\t<meta name=\"google-site-verification\" content=\"-01Tt29FgD8frNEEpRik8kzbF8-9TRCVGsm93a0wCBA\" \/>\n\t\t<meta property=\"og:locale\" content=\"tr_TR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"\u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"MS ilac\u0131 i\u00e7in SGK onay\u0131 bekleniyor | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi\" \/>\n\t\t<meta property=\"og:description\" content=\"M\u0130LL\u0130YET, 3 Mart 2015 T\u00fcrk Eczac\u0131lar\u0131 Birli\u011fi, MS hastalar\u0131n\u0131n kulland\u0131\u011f\u0131 ila\u00e7larda 4 ayd\u0131r s\u0131k\u0131nt\u0131 ya\u015fand\u0131\u011f\u0131 iddialar\u0131na yan\u0131t verdi. Genel Sekreter Harun K\u0131z\u0131lay, Gilenya ve Tecfidera&#039;n\u0131n temini konusunda bir s\u0131k\u0131nt\u0131 olmad\u0131\u011f\u0131n\u0131 ancak Sosyal G\u00fcvenlik Kurumu&#039;nun Tysabri isimli ilac\u0131n kullan\u0131m\u0131na dair de\u011fi\u015fiklik yapt\u0131\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. K\u0131z\u0131lay, &quot;Gilenya isimli ila\u00e7, piyasada 2 y\u0131ld\u0131r ruhsatl\u0131 ama geri \u00f6deme listesinde olmad\u0131\u011f\u0131\" \/>\n\t\t<meta property=\"og:url\" content=\"http:\/\/www.ced.org.tr\/?p=4742\" \/>\n\t\t<meta property=\"fb:app_id\" content=\"1929982940611222\" \/>\n\t\t<meta property=\"fb:admins\" content=\"343956055774962,212758298769685,1829947477319551\" \/>\n\t\t<meta property=\"og:image\" content=\"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2021\/07\/cropped-cropped-CEDLOGO.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"208\" \/>\n\t\t<meta property=\"og:image:height\" content=\"144\" \/>\n\t\t<meta property=\"article:tag\" content=\"sa\u011fl\u0131ktan haberler\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2015-03-04T15:23:03+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2015-03-04T15:23:03+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/groups\/1502807510044536\/\" \/>\n\t\t<meta property=\"article:author\" content=\"http:\/\/\u00c7a\u011fda\u015f%20Eczac\u0131lar%20\u0130stanbul\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@CagdasEczacilar\" \/>\n\t\t<meta name=\"twitter:title\" content=\"MS ilac\u0131 i\u00e7in SGK onay\u0131 bekleniyor | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi\" \/>\n\t\t<meta name=\"twitter:description\" content=\"M\u0130LL\u0130YET, 3 Mart 2015 T\u00fcrk Eczac\u0131lar\u0131 Birli\u011fi, MS hastalar\u0131n\u0131n kulland\u0131\u011f\u0131 ila\u00e7larda 4 ayd\u0131r s\u0131k\u0131nt\u0131 ya\u015fand\u0131\u011f\u0131 iddialar\u0131na yan\u0131t verdi. Genel Sekreter Harun K\u0131z\u0131lay, Gilenya ve Tecfidera&#039;n\u0131n temini konusunda bir s\u0131k\u0131nt\u0131 olmad\u0131\u011f\u0131n\u0131 ancak Sosyal G\u00fcvenlik Kurumu&#039;nun Tysabri isimli ilac\u0131n kullan\u0131m\u0131na dair de\u011fi\u015fiklik yapt\u0131\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. K\u0131z\u0131lay, &quot;Gilenya isimli ila\u00e7, piyasada 2 y\u0131ld\u0131r ruhsatl\u0131 ama geri \u00f6deme listesinde olmad\u0131\u011f\u0131\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@CEDistanbul\" \/>\n\t\t<meta name=\"twitter:image\" content=\"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2021\/07\/CEDLOGO.jpg\" \/>\n\t\t<meta name=\"twitter:label1\" content=\"Taraf\u0131ndan yaz\u0131lm\u0131\u015ft\u0131r\" \/>\n\t\t<meta name=\"twitter:data1\" content=\"CED \u0130STANBUL\" \/>\n\t\t<meta name=\"twitter:label2\" content=\"Est. okuma zaman\u0131\" \/>\n\t\t<meta name=\"twitter:data2\" content=\"1 dakika\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=4742#article\",\"name\":\"MS ilac\\u0131 i\\u00e7in SGK onay\\u0131 bekleniyor | \\u00c7a\\u011fda\\u015f Eczac\\u0131lar Derne\\u011fi\",\"headline\":\"MS ilac\\u0131 i\\u00e7in SGK onay\\u0131 bekleniyor\",\"author\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?author=1#author\"},\"publisher\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/wp-content\\\/uploads\\\/2014\\\/05\\\/ced_favicon.png\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#articleImage\",\"width\":160,\"height\":169},\"datePublished\":\"2015-03-04T17:23:03+02:00\",\"dateModified\":\"2015-03-04T17:23:03+02:00\",\"inLanguage\":\"tr-TR\",\"mainEntityOfPage\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=4742#webpage\"},\"isPartOf\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=4742#webpage\"},\"articleSection\":\"Sa\\u011fl\\u0131ktan Haberler\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=4742#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#listItem\",\"position\":1,\"name\":\"Ev\",\"item\":\"http:\\\/\\\/www.ced.org.tr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=1#listItem\",\"name\":\"\\u00c7ED\"}},{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=1#listItem\",\"position\":2,\"name\":\"\\u00c7ED\",\"item\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=1\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=62#listItem\",\"name\":\"Sa\\u011fl\\u0131ktan Haberler\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#listItem\",\"name\":\"Ev\"}},{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=62#listItem\",\"position\":3,\"name\":\"Sa\\u011fl\\u0131ktan Haberler\",\"item\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=62\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=4742#listItem\",\"name\":\"MS ilac\\u0131 i\\u00e7in SGK onay\\u0131 bekleniyor\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=1#listItem\",\"name\":\"\\u00c7ED\"}},{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=4742#listItem\",\"position\":4,\"name\":\"MS ilac\\u0131 i\\u00e7in SGK onay\\u0131 bekleniyor\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=62#listItem\",\"name\":\"Sa\\u011fl\\u0131ktan Haberler\"}}]},{\"@type\":\"Organization\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#organization\",\"name\":\"\\u00c7A\\u011eDA\\u015e ECZACILAR DERNE\\u011e\\u0130\",\"description\":\"Herkes i\\u00e7in e\\u015fit, paras\\u0131z, ula\\u015f\\u0131labilir bir sa\\u011fl\\u0131k hizmeti\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/wp-content\\\/uploads\\\/2014\\\/05\\\/ced_favicon.png\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=4742\\\/#organizationLogo\",\"width\":160,\"height\":169},\"image\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=4742\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/groups\\\/1502807510044536\\\/\",\"https:\\\/\\\/twitter.com\\\/CagdasEczacilar\",\"https:\\\/\\\/www.instagram.com\\\/cagdaseczacilaristanbul\\\/\"]},{\"@type\":\"Person\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?author=1#author\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/?author=1\",\"name\":\"CED \\u0130STANBUL\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=4742#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/268db36756a52d57bae55f9ffde5852f0c9bbd270ed5c7941979e1563edc6d07?s=96&d=retro&r=g\",\"width\":96,\"height\":96,\"caption\":\"CED \\u0130STANBUL\"},\"sameAs\":[\"http:\\\/\\\/\\u00c7a\\u011fda\\u015f%20Eczac\\u0131lar%20\\u0130stanbul\",\"@CEDistanbul\"]},{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=4742#webpage\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=4742\",\"name\":\"MS ilac\\u0131 i\\u00e7in SGK onay\\u0131 bekleniyor | \\u00c7a\\u011fda\\u015f Eczac\\u0131lar Derne\\u011fi\",\"description\":\"M\\u0130LL\\u0130YET, 3 Mart 2015 T\\u00fcrk Eczac\\u0131lar\\u0131 Birli\\u011fi, MS hastalar\\u0131n\\u0131n kulland\\u0131\\u011f\\u0131 ila\\u00e7larda 4 ayd\\u0131r s\\u0131k\\u0131nt\\u0131 ya\\u015fand\\u0131\\u011f\\u0131 iddialar\\u0131na yan\\u0131t verdi. Genel Sekreter Harun K\\u0131z\\u0131lay, Gilenya ve Tecfidera'n\\u0131n temini konusunda bir s\\u0131k\\u0131nt\\u0131 olmad\\u0131\\u011f\\u0131n\\u0131 ancak Sosyal G\\u00fcvenlik Kurumu'nun Tysabri isimli ilac\\u0131n kullan\\u0131m\\u0131na dair de\\u011fi\\u015fiklik yapt\\u0131\\u011f\\u0131n\\u0131 a\\u00e7\\u0131klad\\u0131. K\\u0131z\\u0131lay, \\\"Gilenya isimli ila\\u00e7, piyasada 2 y\\u0131ld\\u0131r ruhsatl\\u0131 ama geri \\u00f6deme listesinde olmad\\u0131\\u011f\\u0131\",\"inLanguage\":\"tr-TR\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#website\"},\"breadcrumb\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=4742#breadcrumblist\"},\"author\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?author=1#author\"},\"creator\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?author=1#author\"},\"datePublished\":\"2015-03-04T17:23:03+02:00\",\"dateModified\":\"2015-03-04T17:23:03+02:00\"},{\"@type\":\"WebSite\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#website\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/\",\"name\":\"\\u00c7a\\u011fda\\u015f Eczac\\u0131lar Derne\\u011fi\",\"description\":\"Herkes i\\u00e7in e\\u015fit, paras\\u0131z, ula\\u015f\\u0131labilir bir sa\\u011fl\\u0131k hizmeti\",\"inLanguage\":\"tr-TR\",\"publisher\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"MS ilac\u0131 i\u00e7in SGK onay\u0131 bekleniyor | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","description":"M\u0130LL\u0130YET, 3 Mart 2015 T\u00fcrk Eczac\u0131lar\u0131 Birli\u011fi, MS hastalar\u0131n\u0131n kulland\u0131\u011f\u0131 ila\u00e7larda 4 ayd\u0131r s\u0131k\u0131nt\u0131 ya\u015fand\u0131\u011f\u0131 iddialar\u0131na yan\u0131t verdi. Genel Sekreter Harun K\u0131z\u0131lay, Gilenya ve Tecfidera'n\u0131n temini konusunda bir s\u0131k\u0131nt\u0131 olmad\u0131\u011f\u0131n\u0131 ancak Sosyal G\u00fcvenlik Kurumu'nun Tysabri isimli ilac\u0131n kullan\u0131m\u0131na dair de\u011fi\u015fiklik yapt\u0131\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. K\u0131z\u0131lay, \"Gilenya isimli ila\u00e7, piyasada 2 y\u0131ld\u0131r ruhsatl\u0131 ama geri \u00f6deme listesinde olmad\u0131\u011f\u0131","canonical_url":"http:\/\/www.ced.org.tr\/?p=4742","robots":"max-image-preview:large","keywords":"sa\u011fl\u0131ktan haberler","webmasterTools":{"google-site-verification":"4\/PADeybIVXNi1FWDn2PVVeqiyUv8gGZqu7DNmOEZBNDKJiHEdIk47RKA","msvalidate.01":"4\/PADeybIVXNi1FWDn2PVVeqiyUv8gGZqu7DNmOEZBNDKJiHEdIk47RKA","p:domain_verify":"-01Tt29FgD8frNEEpRik8kzbF8-9TRCVGsm93a0wCBA","miscellaneous":"&lt;meta name=\"google-site-verification\" content=\"-01Tt29FgD8frNEEpRik8kzbF8-9TRCVGsm93a0wCBA\" \/&gt;"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/www.ced.org.tr\/?p=4742#article","name":"MS ilac\u0131 i\u00e7in SGK onay\u0131 bekleniyor | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","headline":"MS ilac\u0131 i\u00e7in SGK onay\u0131 bekleniyor","author":{"@id":"http:\/\/www.ced.org.tr\/?author=1#author"},"publisher":{"@id":"http:\/\/www.ced.org.tr\/#organization"},"image":{"@type":"ImageObject","url":"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2014\/05\/ced_favicon.png","@id":"http:\/\/www.ced.org.tr\/#articleImage","width":160,"height":169},"datePublished":"2015-03-04T17:23:03+02:00","dateModified":"2015-03-04T17:23:03+02:00","inLanguage":"tr-TR","mainEntityOfPage":{"@id":"http:\/\/www.ced.org.tr\/?p=4742#webpage"},"isPartOf":{"@id":"http:\/\/www.ced.org.tr\/?p=4742#webpage"},"articleSection":"Sa\u011fl\u0131ktan Haberler"},{"@type":"BreadcrumbList","@id":"http:\/\/www.ced.org.tr\/?p=4742#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/#listItem","position":1,"name":"Ev","item":"http:\/\/www.ced.org.tr\/","nextItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?cat=1#listItem","name":"\u00c7ED"}},{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?cat=1#listItem","position":2,"name":"\u00c7ED","item":"http:\/\/www.ced.org.tr\/?cat=1","nextItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?cat=62#listItem","name":"Sa\u011fl\u0131ktan Haberler"},"previousItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/#listItem","name":"Ev"}},{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?cat=62#listItem","position":3,"name":"Sa\u011fl\u0131ktan Haberler","item":"http:\/\/www.ced.org.tr\/?cat=62","nextItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?p=4742#listItem","name":"MS ilac\u0131 i\u00e7in SGK onay\u0131 bekleniyor"},"previousItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?cat=1#listItem","name":"\u00c7ED"}},{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?p=4742#listItem","position":4,"name":"MS ilac\u0131 i\u00e7in SGK onay\u0131 bekleniyor","previousItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?cat=62#listItem","name":"Sa\u011fl\u0131ktan Haberler"}}]},{"@type":"Organization","@id":"http:\/\/www.ced.org.tr\/#organization","name":"\u00c7A\u011eDA\u015e ECZACILAR DERNE\u011e\u0130","description":"Herkes i\u00e7in e\u015fit, paras\u0131z, ula\u015f\u0131labilir bir sa\u011fl\u0131k hizmeti","url":"http:\/\/www.ced.org.tr\/","logo":{"@type":"ImageObject","url":"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2014\/05\/ced_favicon.png","@id":"http:\/\/www.ced.org.tr\/?p=4742\/#organizationLogo","width":160,"height":169},"image":{"@id":"http:\/\/www.ced.org.tr\/?p=4742\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/groups\/1502807510044536\/","https:\/\/twitter.com\/CagdasEczacilar","https:\/\/www.instagram.com\/cagdaseczacilaristanbul\/"]},{"@type":"Person","@id":"http:\/\/www.ced.org.tr\/?author=1#author","url":"http:\/\/www.ced.org.tr\/?author=1","name":"CED \u0130STANBUL","image":{"@type":"ImageObject","@id":"http:\/\/www.ced.org.tr\/?p=4742#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/268db36756a52d57bae55f9ffde5852f0c9bbd270ed5c7941979e1563edc6d07?s=96&d=retro&r=g","width":96,"height":96,"caption":"CED \u0130STANBUL"},"sameAs":["http:\/\/\u00c7a\u011fda\u015f%20Eczac\u0131lar%20\u0130stanbul","@CEDistanbul"]},{"@type":"WebPage","@id":"http:\/\/www.ced.org.tr\/?p=4742#webpage","url":"http:\/\/www.ced.org.tr\/?p=4742","name":"MS ilac\u0131 i\u00e7in SGK onay\u0131 bekleniyor | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","description":"M\u0130LL\u0130YET, 3 Mart 2015 T\u00fcrk Eczac\u0131lar\u0131 Birli\u011fi, MS hastalar\u0131n\u0131n kulland\u0131\u011f\u0131 ila\u00e7larda 4 ayd\u0131r s\u0131k\u0131nt\u0131 ya\u015fand\u0131\u011f\u0131 iddialar\u0131na yan\u0131t verdi. Genel Sekreter Harun K\u0131z\u0131lay, Gilenya ve Tecfidera'n\u0131n temini konusunda bir s\u0131k\u0131nt\u0131 olmad\u0131\u011f\u0131n\u0131 ancak Sosyal G\u00fcvenlik Kurumu'nun Tysabri isimli ilac\u0131n kullan\u0131m\u0131na dair de\u011fi\u015fiklik yapt\u0131\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. K\u0131z\u0131lay, \"Gilenya isimli ila\u00e7, piyasada 2 y\u0131ld\u0131r ruhsatl\u0131 ama geri \u00f6deme listesinde olmad\u0131\u011f\u0131","inLanguage":"tr-TR","isPartOf":{"@id":"http:\/\/www.ced.org.tr\/#website"},"breadcrumb":{"@id":"http:\/\/www.ced.org.tr\/?p=4742#breadcrumblist"},"author":{"@id":"http:\/\/www.ced.org.tr\/?author=1#author"},"creator":{"@id":"http:\/\/www.ced.org.tr\/?author=1#author"},"datePublished":"2015-03-04T17:23:03+02:00","dateModified":"2015-03-04T17:23:03+02:00"},{"@type":"WebSite","@id":"http:\/\/www.ced.org.tr\/#website","url":"http:\/\/www.ced.org.tr\/","name":"\u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","description":"Herkes i\u00e7in e\u015fit, paras\u0131z, ula\u015f\u0131labilir bir sa\u011fl\u0131k hizmeti","inLanguage":"tr-TR","publisher":{"@id":"http:\/\/www.ced.org.tr\/#organization"}}]},"og:locale":"tr_TR","og:site_name":"\u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","og:type":"article","og:title":"MS ilac\u0131 i\u00e7in SGK onay\u0131 bekleniyor | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","og:description":"M\u0130LL\u0130YET, 3 Mart 2015 T\u00fcrk Eczac\u0131lar\u0131 Birli\u011fi, MS hastalar\u0131n\u0131n kulland\u0131\u011f\u0131 ila\u00e7larda 4 ayd\u0131r s\u0131k\u0131nt\u0131 ya\u015fand\u0131\u011f\u0131 iddialar\u0131na yan\u0131t verdi. Genel Sekreter Harun K\u0131z\u0131lay, Gilenya ve Tecfidera'n\u0131n temini konusunda bir s\u0131k\u0131nt\u0131 olmad\u0131\u011f\u0131n\u0131 ancak Sosyal G\u00fcvenlik Kurumu'nun Tysabri isimli ilac\u0131n kullan\u0131m\u0131na dair de\u011fi\u015fiklik yapt\u0131\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. K\u0131z\u0131lay, &quot;Gilenya isimli ila\u00e7, piyasada 2 y\u0131ld\u0131r ruhsatl\u0131 ama geri \u00f6deme listesinde olmad\u0131\u011f\u0131","og:url":"http:\/\/www.ced.org.tr\/?p=4742","fb:app_id":"1929982940611222","fb:admins":"343956055774962,212758298769685,1829947477319551","og:image":"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2021\/07\/cropped-cropped-CEDLOGO.jpg","og:image:width":208,"og:image:height":144,"article:tag":["sa\u011fl\u0131ktan haberler"],"article:published_time":"2015-03-04T15:23:03+00:00","article:modified_time":"2015-03-04T15:23:03+00:00","article:publisher":"https:\/\/www.facebook.com\/groups\/1502807510044536\/","article:author":"http:\/\/\u00c7a\u011fda\u015f%20Eczac\u0131lar%20\u0130stanbul","twitter:card":"summary_large_image","twitter:site":"@CagdasEczacilar","twitter:title":"MS ilac\u0131 i\u00e7in SGK onay\u0131 bekleniyor | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","twitter:description":"M\u0130LL\u0130YET, 3 Mart 2015 T\u00fcrk Eczac\u0131lar\u0131 Birli\u011fi, MS hastalar\u0131n\u0131n kulland\u0131\u011f\u0131 ila\u00e7larda 4 ayd\u0131r s\u0131k\u0131nt\u0131 ya\u015fand\u0131\u011f\u0131 iddialar\u0131na yan\u0131t verdi. Genel Sekreter Harun K\u0131z\u0131lay, Gilenya ve Tecfidera'n\u0131n temini konusunda bir s\u0131k\u0131nt\u0131 olmad\u0131\u011f\u0131n\u0131 ancak Sosyal G\u00fcvenlik Kurumu'nun Tysabri isimli ilac\u0131n kullan\u0131m\u0131na dair de\u011fi\u015fiklik yapt\u0131\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. K\u0131z\u0131lay, &quot;Gilenya isimli ila\u00e7, piyasada 2 y\u0131ld\u0131r ruhsatl\u0131 ama geri \u00f6deme listesinde olmad\u0131\u011f\u0131","twitter:creator":"@CEDistanbul","twitter:image":"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2021\/07\/CEDLOGO.jpg","twitter:label1":"Taraf\u0131ndan yaz\u0131lm\u0131\u015ft\u0131r","twitter:data1":"CED \u0130STANBUL","twitter:label2":"Est. okuma zaman\u0131","twitter:data2":"1 dakika"},"aioseo_meta_data":{"post_id":"4742","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[],"defaultGraph":"","defaultPostTypeGraph":""},"schema_type":null,"schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2021-01-13 06:10:30","updated":"2025-06-04 02:08:30","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"seo_analyzer_scan_date":null},"jetpack_sharing_enabled":true,"jetpack-related-posts":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/4742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4742"}],"version-history":[{"count":1,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/4742\/revisions"}],"predecessor-version":[{"id":4743,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/4742\/revisions\/4743"}],"wp:attachment":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4742"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4742"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}